CSL Names Deborah Waterhouse as CEO in Strategic Move
A Key Transition: Deborah Waterhouse Takes the Helm In a move that's sure to jolt the biopharma sphere, CSL Limited just handed the CEO reins over to Deborah Waterhouse. Set to start officially on February 1, 2027, this strategic appointment seems well plotted after a diligent global hunt by CSL's board for someone who can drive their enterprise into its next surge of...
Continue Reading